HK Stock MarketDetailed Quotes

02607 SH PHARMA

Watchlist
  • 11.320
  • +0.100+0.89%
Market Closed Apr 26 16:08 CST
41.92BMarket Cap10.02P/E (TTM)

SH PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Cash flow from operating activities
Profit adjustment
Impairment and provisions:
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Revaluation surplus:
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Asset sale loss (gain):
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Depreciation and amortization:
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Operating profit before the change of operating capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Change of operating capital
Cash  from business operations
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Net cash from operations
-108.65%-5.47B
10.29%5.23B
1,550.33%2.3B
394.58%1.64B
-5.35%-2.62B
-6.28%4.74B
-105.43%-158.75M
-125.62%-556.18M
-126.37%-2.49B
-26.06%5.06B
Cash flow from investment activities
Sale of fixed assets
-95.96%815.73K
11.73%179.15M
34.59%147.03M
-9.00%94.4M
-67.91%20.22M
-16.01%160.34M
50.90%109.24M
95.21%103.74M
362.59%62.99M
-50.27%190.9M
Purchase of fixed assets
-25.93%-871.62M
-10.64%-2.97B
-16.91%-2.28B
-46.70%-1.5B
-19.43%-692.12M
34.81%-2.68B
-9.67%-1.95B
10.89%-1.03B
0.71%-579.51M
-36.84%-4.12B
Sale of subsidiaries
105.03%11.51M
-99.53%500K
----
----
--5.62M
-6.07%106.8M
--3.54M
----
----
3.24%113.7M
Acquisition of subsidiaries
96.94%-4.03M
-323.42%-357.08M
38.99%-156.75M
20.64%-150.98M
22.31%-132.08M
92.69%-84.33M
74.56%-256.95M
77.69%-190.26M
-319.74%-170M
46.52%-1.15B
Recovery of cash from investments
8.92%10.05B
-8.54%26.88B
10.25%23.58B
15.83%12.54B
--9.23B
1,058.86%29.39B
1,021.22%21.39B
1,100.77%10.83B
----
-39.23%2.54B
Cash on investment
33.81%-7.1B
31.01%-27.38B
25.11%-25.38B
33.01%-14.33B
---10.73B
-1,160.67%-39.68B
-1,231.26%-33.89B
-1,852.30%-21.39B
----
29.91%-3.15B
Other items in the investment business
-227.48%-244.95M
254.49%1.15B
112.62%1.09B
189.01%728.7M
246.73%192.15M
174.60%325.58M
154.14%513.97M
124.04%252.13M
104.50%55.42M
-113.29%-436.41M
Net cash from investment operations
187.44%1.84B
80.02%-2.49B
78.70%-3B
77.10%-2.61B
-233.74%-2.11B
-107.35%-12.47B
-227.02%-14.08B
-257.63%-11.42B
69.01%-631.1M
-252.68%-6.02B
Net cash before financing
23.21%-3.63B
135.44%2.74B
95.11%-697.09M
91.85%-976.23M
-51.53%-4.73B
-710.04%-7.73B
-930.42%-14.24B
-1,072.13%-11.97B
0.49%-3.12B
-118.57%-954.25M
Cash flow from financing activities
New borrowing
-8.90%18.44B
31.95%64.2B
29.44%46.82B
30.14%33.9B
39.89%20.24B
29.55%48.65B
12.65%36.17B
146.99%26.05B
28.11%14.46B
2.13%37.55B
Refund
14.68%-17.41B
-20.95%-72.34B
-16.20%-50.5B
-26.19%-38.39B
-32.18%-20.41B
-14.54%-59.81B
0.69%-43.46B
-63.21%-30.42B
-10.50%-15.44B
-9.75%-52.21B
Issuance of bonds
-50.00%3B
0.03%15B
-20.00%12B
33.32%12B
0.04%6B
-21.06%14.99B
-6.23%15B
-9.98%9B
19.98%6B
51.99%18.99B
Dividends paid - financing
32.40%-657.03M
-30.44%-4.92B
-38.72%-4.36B
-40.33%-1.39B
-97.72%-971.89M
-13.41%-3.77B
-8.23%-3.14B
-15.99%-993.22M
-23.55%-491.55M
5.53%-3.32B
Absorb investment income
----
-97.49%354.28M
-97.46%355.19M
-97.75%314.36M
-98.88%156.81M
8,239.98%14.12B
13,400.69%14B
25,097.43%14B
1,160.28%13.96B
19.64%169.34M
Other items of the financing business
83.70%-113.39M
-0.48%-2.06B
-7.45%-1.52B
1.38%-1.29B
22.17%-695.79M
-629.79%-2.05B
-290.64%-1.42B
-288.42%-1.31B
-788.40%-894.02M
-8.96%387.26M
Net cash from financing operations
-24.64%3.25B
-98.09%231.85M
-83.70%2.8B
-68.55%5.13B
-75.49%4.31B
675.32%12.14B
648.59%17.16B
808.77%16.32B
501.61%17.59B
224.14%1.57B
Effect of rate
161.07%7.74M
55.14%-5.58M
-374.02%-60.84M
4.02%-948.93K
-1,914.09%-12.67M
75.28%-12.44M
123.86%22.2M
10.28%-988.68K
-95.99%698.35K
-185.48%-50.32M
Net Cash
12.88%-373.88M
-32.54%2.97B
-30.56%2.04B
-4.34%4.15B
-102.97%-429.16M
683.59%4.4B
259.49%2.93B
461.88%4.34B
7,534.36%14.47B
-85.47%561.06M
Begining period cash
12.09%27.5B
21.83%24.53B
21.83%24.53B
21.83%24.53B
21.83%24.53B
2.87%20.14B
2.87%20.14B
2.87%20.14B
2.87%20.14B
24.56%19.58B
Cash at the end
12.53%27.13B
12.09%27.5B
15.17%26.57B
17.19%28.69B
-30.36%24.1B
21.83%24.53B
13.14%23.07B
20.30%24.48B
78.58%34.61B
2.87%20.14B
Cash balance analysis
Cash and cash equivalent balance
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Cash flow from operating activities
Profit adjustment
Impairment and provisions: --0--0--0--0--0--0--0--0--0--0
Revaluation surplus: --0--0--0--0--0--0--0--0--0--0
Asset sale loss (gain): --0--0--0--0--0--0--0--0--0--0
Depreciation and amortization: --0--0--0--0--0--0--0--0--0--0
Operating profit before the change of operating capital --0--0--0--0--0--0--0--0--0--0
Change of operating capital
Cash  from business operations --0--0--0--0--0--0--0--0--0--0
Net cash from operations -108.65%-5.47B10.29%5.23B1,550.33%2.3B394.58%1.64B-5.35%-2.62B-6.28%4.74B-105.43%-158.75M-125.62%-556.18M-126.37%-2.49B-26.06%5.06B
Cash flow from investment activities
Sale of fixed assets -95.96%815.73K11.73%179.15M34.59%147.03M-9.00%94.4M-67.91%20.22M-16.01%160.34M50.90%109.24M95.21%103.74M362.59%62.99M-50.27%190.9M
Purchase of fixed assets -25.93%-871.62M-10.64%-2.97B-16.91%-2.28B-46.70%-1.5B-19.43%-692.12M34.81%-2.68B-9.67%-1.95B10.89%-1.03B0.71%-579.51M-36.84%-4.12B
Sale of subsidiaries 105.03%11.51M-99.53%500K----------5.62M-6.07%106.8M--3.54M--------3.24%113.7M
Acquisition of subsidiaries 96.94%-4.03M-323.42%-357.08M38.99%-156.75M20.64%-150.98M22.31%-132.08M92.69%-84.33M74.56%-256.95M77.69%-190.26M-319.74%-170M46.52%-1.15B
Recovery of cash from investments 8.92%10.05B-8.54%26.88B10.25%23.58B15.83%12.54B--9.23B1,058.86%29.39B1,021.22%21.39B1,100.77%10.83B-----39.23%2.54B
Cash on investment 33.81%-7.1B31.01%-27.38B25.11%-25.38B33.01%-14.33B---10.73B-1,160.67%-39.68B-1,231.26%-33.89B-1,852.30%-21.39B----29.91%-3.15B
Other items in the investment business -227.48%-244.95M254.49%1.15B112.62%1.09B189.01%728.7M246.73%192.15M174.60%325.58M154.14%513.97M124.04%252.13M104.50%55.42M-113.29%-436.41M
Net cash from investment operations 187.44%1.84B80.02%-2.49B78.70%-3B77.10%-2.61B-233.74%-2.11B-107.35%-12.47B-227.02%-14.08B-257.63%-11.42B69.01%-631.1M-252.68%-6.02B
Net cash before financing 23.21%-3.63B135.44%2.74B95.11%-697.09M91.85%-976.23M-51.53%-4.73B-710.04%-7.73B-930.42%-14.24B-1,072.13%-11.97B0.49%-3.12B-118.57%-954.25M
Cash flow from financing activities
New borrowing -8.90%18.44B31.95%64.2B29.44%46.82B30.14%33.9B39.89%20.24B29.55%48.65B12.65%36.17B146.99%26.05B28.11%14.46B2.13%37.55B
Refund 14.68%-17.41B-20.95%-72.34B-16.20%-50.5B-26.19%-38.39B-32.18%-20.41B-14.54%-59.81B0.69%-43.46B-63.21%-30.42B-10.50%-15.44B-9.75%-52.21B
Issuance of bonds -50.00%3B0.03%15B-20.00%12B33.32%12B0.04%6B-21.06%14.99B-6.23%15B-9.98%9B19.98%6B51.99%18.99B
Dividends paid - financing 32.40%-657.03M-30.44%-4.92B-38.72%-4.36B-40.33%-1.39B-97.72%-971.89M-13.41%-3.77B-8.23%-3.14B-15.99%-993.22M-23.55%-491.55M5.53%-3.32B
Absorb investment income -----97.49%354.28M-97.46%355.19M-97.75%314.36M-98.88%156.81M8,239.98%14.12B13,400.69%14B25,097.43%14B1,160.28%13.96B19.64%169.34M
Other items of the financing business 83.70%-113.39M-0.48%-2.06B-7.45%-1.52B1.38%-1.29B22.17%-695.79M-629.79%-2.05B-290.64%-1.42B-288.42%-1.31B-788.40%-894.02M-8.96%387.26M
Net cash from financing operations -24.64%3.25B-98.09%231.85M-83.70%2.8B-68.55%5.13B-75.49%4.31B675.32%12.14B648.59%17.16B808.77%16.32B501.61%17.59B224.14%1.57B
Effect of rate 161.07%7.74M55.14%-5.58M-374.02%-60.84M4.02%-948.93K-1,914.09%-12.67M75.28%-12.44M123.86%22.2M10.28%-988.68K-95.99%698.35K-185.48%-50.32M
Net Cash 12.88%-373.88M-32.54%2.97B-30.56%2.04B-4.34%4.15B-102.97%-429.16M683.59%4.4B259.49%2.93B461.88%4.34B7,534.36%14.47B-85.47%561.06M
Begining period cash 12.09%27.5B21.83%24.53B21.83%24.53B21.83%24.53B21.83%24.53B2.87%20.14B2.87%20.14B2.87%20.14B2.87%20.14B24.56%19.58B
Cash at the end 12.53%27.13B12.09%27.5B15.17%26.57B17.19%28.69B-30.36%24.1B21.83%24.53B13.14%23.07B20.30%24.48B78.58%34.61B2.87%20.14B
Cash balance analysis
Cash and cash equivalent balance --0--0--0--0--0--0--0--0--0--0
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg